Lowe Christopher P.
COO & Chief Financial Officer at IRLA; C.F.O. and C.B.O. at Anthera Pharmaceuticals Inc
- Sold, on record
- $4.1M
- Dollars the filings state
- Form 4 sales
- 8
- Latest Oct 5, 2021
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- IRLAIRulya Therapeutics Inc.COO & Chief Financial Officer
- Anthera Pharmaceuticals IncC.F.O. and C.B.O.
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- Anthera Pharmaceuticals Inc135,234 shares
- IRLA46,963 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale Anthera Pharmaceuticals IncUnusualFeb 11, 2011 2011
Sold 80,997 shares
Lowe Christopher P., VP of Administration and CBO
Sold 100% of holdings0 shares leftFirst sale on recordFiling
- 2 Form 4 sale Anthera Pharmaceuticals IncUnusualAug 3, 2011 +173 days
Sold 19,600 shares at $6.99 ($137k)
Lowe Christopher P., Chief Financial Officer & CBO
Sold 80.9% of holdings ($169k position)4,637 shares leftFiling
- 3 Form 4 sale Anthera Pharmaceuticals IncUnusualOct 25, 2011 +83 days
Sold 4,637 shares at $7.07 ($33k)
Lowe Christopher P., Chief Financial Officer & CBO
Sold 100% of holdings ($33k position)0 shares leftFiling
- 4 Form 4 sale Anthera Pharmaceuticals IncPlan not statedNov 3, 2011 +9 days
Sold 15,000 shares at $6.88 ($103k)
Lowe Christopher P., Chief Financial Officer & CBO
Sold 24.5% of holdings ($421k position)46,151 shares left0.8x usual sizeFiling
- 5 Form 4 sale Anthera Pharmaceuticals IncUnusualFeb 1, 2012 +90 days
Sold 15,000 shares at $7.66 ($115k)
Lowe Christopher P., C.F.O. and C.B.O.
Sold 32.5% of holdings ($354k position)31,151 shares left0.9x usual sizeFiling
- 6 Form 4 sale IRLAUnusualJun 28, 2021 +3435 days
Sold 20,000 shares at $54.15 ($1.1M)
Lowe Christopher P., COO & Chief Financial Officer
Sold 100% of holdings ($1.1M position)0 shares leftFirst sale on recordFiling
- 7 Form 4 sale IRLAUnusualAug 16, 2021 +49 days
Sold 22,000 shares at $95.31 ($2.1M)
Lowe Christopher P., COO & Chief Financial Officer
Sold 42.3% of holdings ($5M position)30,000 shares leftFiling
- 8 Form 4 sale IRLAPlan not statedOct 5, 2021 +50 days
Sold 4,963 shares at $98.50 ($489k)
Lowe Christopher P., COO & Chief Financial Officer
Sold 7.6% of holdings ($6.4M position)60,000 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (8)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Oct 5, 2021 | Oct 7, 2021 | IRLA | COO & Chief Financial Officer | Form 4 sale | 4,963 | $489k | 7.6% | Plan not stated | SEC |
| Aug 16, 2021 | Aug 18, 2021 | IRLA | COO & Chief Financial Officer | Form 4 sale | 22,000 | $2.1M | 42.3% | Unusual | SEC |
| Jun 28, 2021 | Jun 30, 2021 | IRLA | COO & Chief Financial Officer | Form 4 sale | 20,000 | $1.1M | 100.0% | Unusual | SEC |
| Feb 1, 2012 | Feb 3, 2012 | Anthera Pharmaceuticals Inc | C.F.O. and C.B.O. | Form 4 sale | 15,000 | $115k | 32.5% | Unusual | SEC |
| Nov 3, 2011 | Nov 4, 2011 | Anthera Pharmaceuticals Inc | Chief Financial Officer & CBO | Form 4 sale | 15,000 | $103k | 24.5% | Plan not stated | SEC |
| Oct 25, 2011 | Oct 27, 2011 | Anthera Pharmaceuticals Inc | Chief Financial Officer & CBO | Form 4 sale | 4,637 | $33k | 100.0% | Unusual | SEC |
| Aug 3, 2011 | Aug 4, 2011 | Anthera Pharmaceuticals Inc | Chief Financial Officer & CBO | Form 4 sale | 19,600 | $137k | 80.9% | Unusual | SEC |
| Feb 11, 2011 | Feb 14, 2011 | Anthera Pharmaceuticals Inc | VP of Administration and CBO | Form 4 sale | 80,997 | 100.0% | Unusual | SEC |